Become A Featured Company

Hempsana: An Emerging Leader in Cannabis 3.0

Ryan Allway

June 15th, 2021

App, Exclusive, News, Top Story

 

The cannabis movement began with the legalization of medical and adult-use cannabis in Canada and parts of the United States. With the Cannabis 2.0 revolution, cannabis producers expanded beyond flower to produce edibles, beverages, vapes, tinctures and other products while cannabidiol (CBD) became legal in many jurisdictions around the world.

The next stage of the industry’s growth—Cannabis 3.0—will be driven by a number of different trends, ranging from data-driven insights to rare cannabinoids to global legalization. In aggregate, these catalysts promise to usher in a new stage of growth for the industry and investors may want to start positioning their portfolios to benefit.

Let’s take a look at why Hempsana Inc., a soon-to-be-public cannabis derivatives specialist, is well-positioned to capitalize on these trends and become a Cannabis 3.0 leader.

Download the company’s investor presentation and receive a going public alert.

A Passion for Health & Wellness

Hempsana is a Canadian cannabis company that specializes in manufacturing cannabis derivatives. After getting its start in 2018, the founders sought to develop safe, natural, and consistent CBD products at an affordable price point. They witnessed first-hand how CBD could provide comfort and support the healthy lifestyle of modern consumers.

The company achieved these goals by completing an EU-GMP and GPP compliant facility at the end of 2020 that combines strict quality controls, exacting standards, and extensive in-process testing capabilities. With its Health Canada Standard Processing License, the company is ready to scale up production in the near-term.

In addition to promoting the health and wellbeing of its customers, Hempsana is dedicated to supporting local businesses in the regions that it operates. The team works with local farmers under a partnership-style business model to ensure that products are made in Canada by Canadians, creating both high-quality products and a consistent supply.

Well-Positioned for Cannabis 3.0

Hempsana aims to become a leader in the Cannabis 3.0 revolution. As an existing industry leader in Cannabis 2.0 crude oil, distillate and isolate, the company can manufacture its own branded products, including oils, tinctures, vape cartridges, topicals, edibles and beauty products, while providing a white label program and a service platform for third parties.

The company has already signed extraction-as-a-service (e.g., toll processing) agreements for over 30,000 kilograms of cannabis biomass and is in process of signing partnerships for cbd infused finished products. These agreements should pave the way toward near-term revenue and establish its business as the cannabis market transitions.

While the company specializes in CBD, it has the capacity to address THC and rare cannabinoids like CBN and Delta 8 that will become the bedrock of the Cannabis 3.0 movement. These rare cannabinoids act as key supplements to endocannabinoids and could become key ingredients in cannabis-based pharmaceuticals—a market projected to reach $50 billion by 2029.

In addition to its focus on rare cannabinoids, Hempsana has plans to expand into global markets as legalization efforts unfold throughout Europe and Asia. The company aims to become a large-scale global producer of CBD and other cannabinoids with its first export products expected during the fourth quarter of this year.

Looking Ahead

Hempsana Inc. is well-positioned to capitalize on the Cannabis 3.0 movement with its rare cannabinoid exposure and global focus. Investors may soon have an opportunity to participate in the company’s potential upside following its business combination agreement with Stralak Resources Inc., paving the way for a go-public transaction.

The company’s management team hails from Teva, Baxter, Sanofi, Deloitte, PwC, CIBC, Eurofins, Tilray, Pfizer, Bayer, and other well-known cannabis, financial and pharmaceutical companies around the world, which provides a further vote of confidence in its ability to execute on its vision and become a leader in the next green wave.

For more information, visit the company’s website or sign up to download their investor presentation and receive a going public alert.

Disclaimer

The above article is sponsored content. CannabisFN.com and CFN Media, have been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: https://cannabisfn.com/legal-disclaimer/

This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.

About Ryan Allway

Mr. Allway has over a decade of experience in the financial markets as both a private investor and financial journalist. He has been actively involved in the cannabis industry since its inception, covering public and private companies.

Network Partners

Follow Us on Social Media

LinkedIn

About CFN Media Group

CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.

Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.

Copyright © Accelerize Inc. · All Rights Reserved · Privacy Policy · Legal Disclaimer

loading